Roth Capital Starts Ligand Pharma (LGND) at Buy
Tweet Send to a FriendGet Alerts LGND Hot Sheet
Price: $28.01 +4.95%
Rating Summary:
3 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Rating Summary:
3 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Trade LGND Now!
Roth Capital initiates coverage on Ligand Pharma (NASDAQ: LGND) with a Buy. PT $25.00.
For an analyst ratings summary and ratings history on Ligand Pharma click here. For more ratings news on Ligand Pharma click here.
Shares of Ligand Pharma closed at $15.62 yesterday, with a 52 week range of $10.16-$18.74.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on Ligand Pharma click here. For more ratings news on Ligand Pharma click here.
Shares of Ligand Pharma closed at $15.62 yesterday, with a 52 week range of $10.16-$18.74.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Topeka Capital Starts Laredo Petroleum (LPI) at Buy, Assets 'Undervalued'
- Topeka Capital Starts Precision Castparts (PCP) at Buy
- Barclays Starts Crown Castle (CCI) at Equalweight
Create E-mail Alert Related Categories
New CoverageRelated Entities
Roth Capital
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
